Related Experiment Video
Updated: Aug 12, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
The role of T-cells in preventing relapse in chronic myelogenous leukemia
1Department of Pediatrics, UCLA School of Medicine 90024.
Abstract:
Bone marrow transplantation is effective in eradicating leukemia in over 90% of patients with chronic myelogenous leukemia (CML). This efficacy relates to some extent to the antileukemia effect of high-dose chemotherapy and radiation. An immune-mediated antileukemia effect of graft-versus-host disease is also important. In CML, a novel T-cell-mediated mechanism of leukemia eradication is also probably active. In this article we describe this novel mechanism, present preliminary data to support the notion and suggest that it might be exploited to treat CML in a context other than bone marrow transplantation.
Related Concept Videos
Cell-mediated Immune Responses
Cells of the Adaptive Immune Response
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

